In vitro, studies showed that using EV-mimetic nanovesicles with a high content of lncRNA-H19 as a delivery vehicle neutralized the suppression of regeneration of hyperglycemia and accelerated chronic wound healing (133). Here, H19 is linked to Hyperglycemia.